Fig. 1From: Pharmacokinetics and biodistribution of a novel anticancer thyrointegrin αvβ3 antagonist: triazole modified tetraiodothyroacetic acid conjugated to polyethylene glycol (P-bi-TAT)Chemical structures of P-bi-TAT (1) and P-mono-TAT (2); and n means the average number of repeating oxyethylene units (90)Back to article page